Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 811 results for "bayer ag"

Bayer AG rechristens its MaterialScience division as Covestro
Autocar Professional

Bayer Material Sciences rechristened Covestro globally

Rechristened as Covestro, the material sciences business will remain a 100 percent subsidiary of Bayer AG. Money Control, 18 hours ago
Covestro now up and running, 1 day ago

Bayer's Latest Stage 2 Trial Could Be A Boon For Shares

Bayer AG (ADR) (OTC: BAYRY) recently finished a mid-stage trial for a heart failure drug, finerenone, which showed a "striking" decline in deaths. Now, a Reuters article informed that the company will move into a final-stage trial before the end of ...
 Benzinga.com2 days ago

Bayer Expands Finerenone Clinical Development Program with Three Phase III Studies for Finerenone in Patients with Diabetic Kidney Disease and Patients with Chronic Heart Failure

WHIPPANY, N.J. , Aug. 31, 2015 /PRNewswire/ --Bayer HealthCare announced today the expansion of the clinical development program for its oral non-steroidal mineralocorticoid receptor antagonist finerenone (BAY 94-8862) with three Phase III studies.
 BioSpace2 days ago Bayer HealthCare Pharmaceuticals (BAYA.F) To Bring Prostate Cancer Awareness To Center Court With Coaches Vs. Cancer Partnership 8/24/2015  ClinicSpace1 week ago Bayer to Bring Prostate Cancer Awareness to Center Court with Coaches vs. Cancer Partnership  Wall Street Select1 week ago Bayer HealthCare Pharmaceuticals To Bring Prostate Cancer Awareness To Center Court With Partnership  BioSpace1 week ago

The pesticide that kills bugs and might help fight cancer

There's a tiny worm that Marijn Dekkers says might embody the future of Bayer AG. Nematodes, which gnaw at peanut and cotton roots, first drew Bayer's attention for destructive purposes. Researchers devised an insecticide that starves them of ...
 Livemint.com4 weeks ago

Polycoat Acquires Crown Polymers, Bayer MaterialScience Launches INSQIN, Global Bioenergies Bio-Isobutene Process to Utilize Sucrose

Hello and welcome to your late week international coatings industry update, brought to you by SpecialChem. The news for this issue was dominated by announcements of fine financial results among industry players. Apparently, the economy overall ...
 Special Chem 4 Coatings Ingredients1 month ago

Bayer CEO Weighs In On Guidance, Listing Of Material Science Business And Syngenta

Bayer AG (ADR)(OTC: BAYRY) reported a 21 percent year-over-year rise to $1.27 billion in second-quarter profits. Marijn Dekkers, CEO of Bayer, was on CNBC to weigh in on the company's guidance and shed light on the listing of its material science ...
 Benzinga.com1 month ago

Earnings at Bayer, Peugeot Send Europe Stocks Higher for 2nd Day

(Bloomberg) -- Better-than-estimated earnings at companies from Bayer AG to PSA Peugeot Citroen pushed European stocks higher for a second day. Bayer, Peugeot and British American Tobacco Plc rose more than 2.7 percent after reporting earnings ...
 La Repubblica1 month ago Europe: Earnings, M&A spur second day of advances in European equities  BT Invest1 month ago

Bayer Earnings Beat Estimates on Blood Thinner, Consumer Brands

(Bloomberg) -- Bayer AG's second-quarter earnings beat analysts estimates, helped by the blood thinner Xarelto and the addition of Merck & Co.'s consumer-health business. Earnings before interest, taxes, amortization, depreciation and special ...
 Washington Post1 month ago Bayer Earnings Beat Estimates on Xarelto and Plastics Division  La Repubblica1 month ago
Pharmaceutical Business Review

Sprint Bioscience signs licensing agreement with Bayer HealthCare

Sprint Bioscience AB, a Sweden-based drug development company, has entered into a collaboration and licensing agreement with Bayer HealthCare AG, a Germany-based company engaged in the research, development, manufacturing and marketing of healthcare ...
 Individual.com1 month ago Bayer, Sprint Bioscience partner to develop new oncology drug candidates  Pharmaceutical Business Review1 month ago

EARNINGS SUMMARY: Details of Bayer AG Q2 Earnings Report

Below are the earnings highlights for Bayer AG (BAYZF.PK): -Net Income: Euro1.64 Bln in Q2 vs. Euro1.22 Bln in the same period last year. -EPS: Euro1.98 in Q2 vs. Euro1.48 in the same period last year. -Revenue: Euro12.09 Bln in Q2 vs.
 RTTNews.com1 month ago Bayer Q2 Profit Climbs; Backs FY15 Earnings Growth View - Quick Facts  Nasdaq1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - bayer ag
Get updated on latest news & your favorite topics right in your inbox!
More     Less